CONVERSE PHARMA LIMITED

Company number 08505543

Date	Type	Description	View / Download
25 Apr 2023	GAZ2	Final Gazette dissolved via compulsory strike-off	(1 page)
17 Jan 2023	GAZ1	First Gazette notice for compulsory strike-off	(1 page)
06 Jun 2022	MR04	Satisfaction of charge 085055430002 in full	(1 page)
31 May 2022	TM01	Termination of appointment of Mark James Gulliford as a director on 30 May 2022	(1 page)
30 Mar 2022	AA01	Current accounting period shortened from 30 March 2021 to 29 March 2021	(1 page)
31 Dec 2021	MR01	Registration of charge 085055430009, created on 21 December 2021	(21 pages)
29 Dec 2021	MR05	All of the property or undertaking has been released from charge 085055430002	(5 pages)
29 Dec 2021	MR04	Satisfaction of charge 085055430007 in full	(4 pages)
29 Dec 2021	MR04	Satisfaction of charge 085055430005 in full	(4 pages)
29 Dec 2021	MR04	Satisfaction of charge 085055430006 in full	(4 pages)
22 Dec 2021	MR01	Registration of charge 085055430008, created on 21 December 2021	(63 pages)
11 Oct 2021	CS01	Confirmation statement made on 30 September 2021 with no updates	(3 pages)
05 Aug 2021	AA	Group of companies' accounts made up to 31 March 2020	(33 pages)
30 Mar 2021	AA01	Current accounting period shortened from 31 March 2020 to 30 March 2020	(1 page)
06 Oct 2020	CS01	Confirmation statement made on 30 September 2020 with no updates	(3 pages)
06 Jul 2020	AP01	Appointment of Rachael Anne Hill as a director on 6 July 2020	(2 pages)
06 Jul 2020	AP01	Appointment of Trudy Joanne Gallagher as a director on 6 July 2020	(2 pages)
06 Jul 2020	AP01	Appointment of Nicola Jane Cook as a director on 6 July 2020	(2 pages)
06 Jul 2020	AP01	Appointment of Mr Matthew Ellis Cundall as a director on 6 July 2020	(2 pages)
06 Jul 2020	AP01	Appointment of Mr Christopher Ian Gulliford as a director on 6 July 2020	(2 pages)
19 Dec 2019	AA	Group of companies' accounts made up to 31 March 2019	(31 pages)
04 Oct 2019	CS01	Confirmation statement made on 30 September 2019 with updates	(4 pages)
10 Sep 2019	TM01	Termination of appointment of Mawdsleys Group Investments Limited as a director on 31 May 2019	(1 page)
08 Jul 2019	SH06	Cancellation of shares. Statement of capital on 31 May 2019 GBP 250,080	(6 pages)
08 Jul 2019	SH03	Purchase of own shares.	(3 pages)